What to Expect in 2021

Podcast: Healthcare Equity, Vaccine Distribution and Predictions for the Future of U.S. Healthcare – Part III | April 14, 2021

In the final episode of A&M Healthcare Industry Group’s podcast series on the impact of the new Administration, Jennifer Bell, Founding Partner of Chamber Hill Strategies and Dr. David Shulkin, Ninth Secretary, U.S. Department of Veterans Affairs, and Peter Urbanowicz, A&M’s Healthcare Industry Group Co-Head, discuss the Biden Administration’s commitment to “equity” in healthcare. They experts also weigh in to provide some perspectives on who is on the “in” and who is on the “out” in this Administration.

Podcast: President Biden’s COVID-19 Plan, Campaign Promises Around Healthcare and What’s to Come for Prescription Drug Pricing – Part II | April 7, 2021

In part two of A&M Healthcare Industry Group’s podcast series, Jennifer Bell, Founding Partner of Chamber Hill Strategies and Dr. David Shulkin, Ninth Secretary, U.S. Department of Veterans Affairs, continue their discussion with Peter Urbanowicz, A&M’s Healthcare Industry Group Co-Head, on the Biden Administration’s impact on healthcare policy by focusing on President Biden’s campaign promises for healthcare and how and when they may come to fruition.  They also discuss the important issue of prescription drug pricing reform and how we can anticipate the Biden Administration and Congress may deal with the issue.

Podcast: The Impact of the New Administration on Healthcare Policy – Part I | March 31, 2021

A&M’s Healthcare Industry Group Co-Head, Peter Urbanowicz, is joined by Dr. David Shulkin, Ninth Secretary of the U.S. Department of Veterans Affairs and Jennifer Bell, Founding Partner of Chamber Hill Strategies, as they discuss and share perspectives on what the Healthcare landscape and future look like under the Biden Administration.

In part one, Dr. Shulkin and Ms. Bell discuss the role of the cabinet secretary and how the White House and cabinet agencies shape healthcare policy. They also discuss the latest $1.9 trillion COVID-19 stimulus bill and how the bill will affect the ACA Exchanges and Medicaid. And, with Democrats holding the Presidency and both Houses of Congress right now, our experts also weigh in on what the future of federal healthcare policy looks like over the next four years.

POLITICO Influence | March 17, 2021

Chamber Hill Strategies has hired Deema Tarazi as a senior associate. She was previously a lobbyist for March of Dimes and plans to register to lobby in her new role as well, according to the firm.

Association of Cancer Executives Annual Meeting | February 9, 2021

Jennifer Bell, founding partner, previewed what 2021 looks like for drug pricing, 340B, and oncology care at the annual meeting of the Association of Cancer Executives.

POLITICO Influence | February 9, 2021

Chamber Hill has hired Ariel Gonzalez as a principal and leading Democrat for the firm. He was most recently senior vice president of public policy and government relations for the March of Dimes.

Politico Playbook | February 9, 2021

Ariel Gonzalez is joining Chamber Hill Strategies as a principal. He most recently was head of government affairs for March of Dimes, and is an AARP alum.

What to Expect in 2021 | February 4, 2021

Check out the latest video interview from the National Association of Elder Law Attorneys’ Federal Advocacy Committee co-chairs with Jennifer Bell of Chamber Hill Strategies and NAELA’s Director of Advocacy, David M. Goldfarb, on what members can expect inside the beltway in 2021; how NAELA navigated advocacy during the COVID-19 crisis; and more!